Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

INDIA: Mumbai Tuberculosis: Deaths Soar at Sewri Hospital, BMC Claims There's No XXDR-TB in the City




 

HealthIndia.com (04.17.13) Aids Weekly Plus

In spite of high admission and TB mortality rates, there have been no surgeries during the last three months at Sewri, Asia’s largest TB hospital. The facility admits approximately 50 new TB patients daily and reports 10 to 20 TB deaths per day. Removing the TB-infected part of the lungs can help some TB patients recover from the disease. The operating rooms at Sewri, a 1,000-bed facility, were closed for six years, but reopened after a 2012 multi-drug resistant TB (MDR TB) scare in Mumbai. However, after only 40 operations—12 of which involved MDR TB cases—the operating theater closed again. Sewri doctors report that an anesthesia machine was broken for a month, and surgeons from other hospitals in Mumbai have refused to operate at Sewri. In 2012, another Mumbai hospital, PD Hinduja Hospital, reported 12 cases of extra extensively drug-resistant TB (XXDR-TB), which does not respond to any TB drugs. Six of the patients have died, and the city’s TB officer Dr. Khetarpal downgraded the status of the remaining six patients to extensively drug-resistant TB (XDR TB), claiming they have responded to treatment. Brihanmumbai Municipal Corporation (BMC) executive health officer Dr. Arun Bamne stated that Mumbai now has 44 XDR TB patients. BMC reported 3,003 new MDR TB cases in Mumbai in 2012. Italy, Iran, and India are the only countries that have reported XXDR-TB cases.



 


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.



Information in this article was accurate in April 18, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.